Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Earnings Preview: Constellation Brands, Inc. (STZ)

I have always believed that a company’s earnings should meet realistic investors’ expectations to support the movement in stock prices. If it is not so, then the company’s stock cannot sustain an upsurge based only on investor sentiment for long. With Constellation Brands, Inc. (NYSE:STZ) about to release its earnings on July 2, the only thought that crosses my mind is whether or not it will be able to perform well enough to sustain its growing share price.

Constellation Brands, Inc. (NYSE:STZ)

The largest wine maker in the world has gained more than 60% in the last year and is still going strong. On average Constellation’s revenue is estimated to rise 6% compared to the same period last year to $674.24 million. On the upper side it can reach up to $689 million. Constellation’s revenue has risen 5% year-on-year in the last four quarters and increased 10% in the most recent quarter.

Constellation Brands, Inc. (NYSE:STZ) has a portfolio of some of the most recognized brands of wine, spirits, and beers in the world such as Corona Extra, Pacifico, St. Pauli Girl, Black Velvet and Fleischmann’s. The company has been strategically adding new products in its wine and spirits business, driving growth in its market share in the U.S. Further, Constellation has increased its distribution points in retail, which should only help the top line and make the estimates more achievable.

About earnings

Currently the earnings for Constellation Brands, Inc. (NYSE:STZ) are estimated to be $0.41 a share, an increase from $0.40 per share, keeping up a positive vibe about the company. The company’s earnings have beaten analysts’ estimates in the last four quarters, with a double-digit surprise in two of them. As everything on the top line and acquisition is falling in place, there is good reason to believe that Constellation might best analysts in this quarter too.

Let’s brew it up

In the last quarter, Anheuser-Busch InBev NV (ADR) (NYSE:BUD) had to sell 50% of its stake in its Crown Imports joint venture to Constellation Brands, Inc. (NYSE:STZ) in order to satisfy an antitrust agreement with the Justice Department. Furthermore, as a part of the deal, Constellation bought the Piedras Negras brewery, which will be the company’s principal production facility of Corona beer and other Crown Import products to the U.S. market.

Post the Modelo deal, Constellation Brands, Inc. (NYSE:STZ) is now the third largest beer producer in the U.S. Moving forward, it has plans to invest $500 million to $600 million in a span of three years to increase its production in Nava and Mexico breweries in order to double its capacity to meet the growing demand of beer in the U.S. It has been noticed previously that beer drinkers are more brand loyal, which should give Constellation Brands, Inc. (NYSE:STZ) more leverage in pricing, thus improving its margins in the long run.

Grab some Buds

Anheuser-Busch InBev NV (ADR) (NYSE:BUD) has also gained immensely from the acquisition of Grupo Modelo. The $20 billion deal will help the company to enter South American markets. Anheuser-Busch InBev has added some of the most recognized beer names to its portfolio. That, along with the business insights and better liquidity position of the company, should only add further value.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.